Open AccessMupirocin Resistance in Isolates of Staphylococcus spp. from Nasal Swabs in a Tertiary Hospital in France
Author(s) -
Sophie TrouilletAssant,
Sacha Flammier,
Anaïs Sapin,
Céline Dupieux,
Oana Dumitrescu,
Anne Tristan,
François Vandenesch,
JeanPhilippe Rasigade,
Frédéric Laurent
Publication year - 2015
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.00274-15
Subject(s) - mupirocin , etest , microbiology and biotechnology , staphylococcus aureus , micrococcaceae , medicine , staphylococcal infections , carriage , antibiotics , staphylococcus , antibacterial agent , biology , methicillin resistant staphylococcus aureus , bacteria , pathology , genetics
Mupirocin is a topical antibiotic largely used to eradicate staphylococcal nasal carriage. Here, we investigated the prevalence of mupirocin-resistant Staphylococcus aureus and coagulase-negative staphylococcal isolates recovered from patients in different wards in a hospital (Lyon, France), which were determined both phenotypically with an Epsilometer test (Etest) and genetically by PCR for mupA and mupB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom